Overview
Myrte Breukink practices in Nijmegen, Netherlands. Breukink is rated as an Elite expert by MediFind in the treatment of Central Serous Chorioretinopathy. Their top areas of expertise are Central Serous Chorioretinopathy, Monoclonal Gammopathy of Undetermined Significance (MGUS), Late-Onset Retinal Degeneration, and Bone Marrow Aspiration.
Their clinical research consists of co-authoring 27 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 25 articles in the study of Central Serous Chorioretinopathy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Central Serous Chorioretinopathy
- Experienced
- Bone Marrow AspirationBreukink isExperienced. Learn about Bone Marrow Aspiration.
- Late-Onset Retinal DegenerationBreukink isExperienced. Learn about Late-Onset Retinal Degeneration.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)